Spironolactone Tablet, Film Coated
Product Images NDC 70518-4470

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 70518-4470). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 01)

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 01)
Chemical structure of spironolactone, displaying a complex steroidal backbone with multiple rings, ketone groups, and a thioacetate functional group as part of its molecular configuration.*
FDA Label Image

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 02)

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 02)
A Kaplan-Meier survival curve graph comparing the probability of an event over months between two groups: patients taking spironolactone (n=822) and those given placebo (n=841). Time is shown on the x-axis (0 to 48 months), and probability on the y-axis (0 to 1.0). The spironolactone group has a higher survival probability throughout the period.*
FDA Label Image

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 03)

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 03)
A forest plot depicting hazard ratios (HR) and 95% confidence intervals (CI) for spironolactone versus placebo across various subgroups. Subgroups include age ranges, sex, race, left ventricular ejection fraction (LVEF) percentages, heart failure type, NYHA class, diabetes status, serum creatinine, creatinine clearance, potassium levels, digoxin use, ACE inhibitor use, and beta blocker use. Each subgroup has HR point estimates with horizontal CIs and sample sizes.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Spironolactone 25 mg film-coated tablets, packaged 100 per box. The label includes dosage instructions to see the insert and states the tablets are round and white. Manufactured by Zydus Pharm and repackaged by RemedyRepack Inc. The label advises protection from light and storage at 20-25°C with permitted excursions.*
FDA Label Image

Mm2 (Spironolactone 25mg 70518 4470 01)

Mm2 (Spironolactone 25mg 70518 4470 01)
Label for spironolactone 25 mg film-coated tablet, quantity one. The tablet is described as round white with imprint 660. Label includes storage instructions, repackaging by RemedyRepack Inc. in Indiana, PA, and manufacturer information for Zydus Pharm, Pennington, NJ. The label specifies that it is prescription only and advises to protect from light.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.